Positron Corporation (POSC)

[JackStraw]

POSC delivers Pharm-Assist to Bogota


Positron Delivers SPECT Based Automated Radiopharmaceutical Dose Dispensing Unit to South American Nuclear Pharmacy
Friday December 19, 11:26 am ET


HOUSTON--(BUSINESS WIRE)--Positron Corporation (POSC.OB) announced today that it has completed the sale and delivery of its SPECT based Nuclear Pharm-AssistTM device to Comci, LTDA in Bogota, Colombia.
The Nuclear Pharm-AssistTM is an automated dose dispensing machine sold to pharmacies and healthcare providers designed to increase productivity, decrease or eliminate exposure issues while offering a platform for USP-797 and regulatory compliance. The Nuclear Pharm-AssistTM streamlines the production and delivery of radiopharmaceuticals allowing for the establishment of unique distribution models within the Nuclear Medicine market.

“We are delighted to work with Comci on our state of the art SPECT based Nuclear Pharm-AssistTM,” said Joe Oliverio, President of Positron. “Our automated dose dispensing technology enables Positron to be more integrated around the sale and distribution of radiopharmaceuticals to our customers.”

About Positron

Positron Corporation is a vertically integrated company in the field of Cardiac Nuclear Medicine. The Company operates through two segments: Molecular Imaging Devices and Radiopharmaceutical Products. The Molecular Imaging Devices segment provides Positron Emission Tomography (PET) scanners and Single Photon Emission Computed Tomography (SPECT) cameras; the Radiopharmaceutical Products segment offers world’s first robotic systems for distribution and delivery of radiopharmaceuticals and provides radiopharmaceutical agents used for the diagnosis of cardiac diseases. The Company is able to offer a total customer solution which includes molecular imaging devices, disease specific software, radiopharmaceutical distribution and delivery systems, and radiopharmaceuticals agents for Cardiac Nuclear Medicine. Positron Corporation was incorporated in 1983 and is currently headquartered in Houston, Texas. Positron’s SPECT and PET cardiac molecular imaging systems and radiopharmaceutical deliver devices are installed in more than 150 hospitals and physician offices around the world. Additional information may be found at http://www.positron.com.

Forward Looking Statements: